A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
NCT00527917
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Interstitial Cystitis
Interventions
DEVICE:
placebo
DEVICE:
Uracyst
Sponsor
Watson Pharmaceuticals